- Home
- XENE vs WLYB Comparison
XENE vs WLYB Comparison
Compare XENE & WLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- WLYB
- Stock Information
- Founded
- XENE 1996
- WLYB 1807
- Country
- XENE Canada
- WLYB United States
- Employees
- XENE N/A
- WLYB N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- WLYB Books
- Sector
- XENE Health Care
- WLYB Consumer Discretionary
- Exchange
- XENE Nasdaq
- WLYB Nasdaq
- Market Cap
- XENE 2.4B
- WLYB 2.4B
- IPO Year
- XENE 2014
- WLYB N/A
- Fundamental
- Price
- XENE $32.63
- WLYB $42.47
- Analyst Decision
- XENE Strong Buy
- WLYB
- Analyst Count
- XENE 11
- WLYB 0
- Target Price
- XENE $54.82
- WLYB N/A
- AVG Volume (30 Days)
- XENE 1.5M
- WLYB 1.6K
- Earning Date
- XENE 08-07-2025
- WLYB 09-04-2025
- Dividend Yield
- XENE N/A
- WLYB 3.31%
- EPS Growth
- XENE N/A
- WLYB N/A
- EPS
- XENE N/A
- WLYB 1.53
- Revenue
- XENE $7,500,000.00
- WLYB $1,677,609,000.00
- Revenue This Year
- XENE N/A
- WLYB $1.75
- Revenue Next Year
- XENE $253.71
- WLYB $2.40
- P/E Ratio
- XENE N/A
- WLYB $27.00
- Revenue Growth
- XENE N/A
- WLYB N/A
- 52 Week Low
- XENE $26.74
- WLYB $37.27
- 52 Week High
- XENE $46.00
- WLYB $52.90
- Technical
- Relative Strength Index (RSI)
- XENE 51.18
- WLYB 48.93
- Support Level
- XENE $31.22
- WLYB $44.65
- Resistance Level
- XENE $33.51
- WLYB $45.41
- Average True Range (ATR)
- XENE 1.18
- WLYB 0.18
- MACD
- XENE 0.04
- WLYB -0.14
- Stochastic Oscillator
- XENE 45.62
- WLYB 0.00
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About WLYB John Wiley & Sons Inc.
John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.